A detailed history of Invenio Wealth Partners LLC transactions in Amgen Inc stock. As of the latest transaction made, Invenio Wealth Partners LLC holds 1,109 shares of AMGN stock, worth $326,633. This represents 0.15% of its overall portfolio holdings.

Number of Shares
1,109
Previous 1,070 3.64%
Holding current value
$326,633
Previous $334 Million 6.88%
% of portfolio
0.15%
Previous 0.17%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$309.38 - $337.38 $12,065 - $13,157
39 Added 3.64%
1,109 $357 Million
Q2 2024

Aug 12, 2024

SELL
$262.75 - $319.31 $525 - $638
-2 Reduced 0.19%
1,070 $334 Million
Q1 2024

May 09, 2024

BUY
$268.87 - $324.56 $29,037 - $35,052
108 Added 11.2%
1,072 $305 Million
Q4 2023

Feb 09, 2024

BUY
$255.7 - $288.46 $34,519 - $38,942
135 Added 16.28%
964 $278 Million
Q3 2023

Nov 13, 2023

BUY
$218.65 - $271.46 $181,260 - $225,040
829 New
829 $223 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $158B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Invenio Wealth Partners LLC Portfolio

Follow Invenio Wealth Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invenio Wealth Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Invenio Wealth Partners LLC with notifications on news.